Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SABRIL for Generalised non-convulsive epilepsy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where SABRIL was used for Generalised non-convulsive epilepsy.

Most Reported Side Effects for SABRIL

Side Effect Reports % Deaths Hosp.
Drug dose omission 168 21.8% 1 11
Convulsion 130 16.8% 5 54
Drug ineffective 68 8.8% 0 3
Death 35 4.5% 35 6
Pneumonia 31 4.0% 6 28
Incorrect dose administered 27 3.5% 0 2
Vomiting 26 3.4% 1 8
Somnolence 25 3.2% 0 3
Wrong technique in drug usage process 24 3.1% 0 0
Malaise 19 2.5% 1 10
Pyrexia 19 2.5% 0 12
Retinal toxicity 18 2.3% 0 0
Drug withdrawal convulsions 16 2.1% 0 3
Infantile spasms 15 1.9% 0 4
Irritability 13 1.7% 0 4

Other Indications for SABRIL

Infantile spasms (389) Complex partial seizures (144) Epilepsy (110) Product used for unknown indication (103) Convulsion (26) Tuberous sclerosis (26) Temporal lobe epilepsy (21) Generalised tonic-clonic seizure (14) Grand mal convulsion (10)

Other Drugs Used for Generalised non-convulsive epilepsy

VIGABATRIN (22) CLOBAZAM (16) LEVETIRACETAM (12) VALPROIC ACID (6) PHENOBARBITAL (5)

Related Pages

SABRIL Full Profile All Generalised non-convulsive epilepsy Drugs SABRIL Demographics SABRIL Timeline